Monday, January 25, 2010
Michael Cook mentions in this brief BioEdge post a couple of examples showing that "the bloom is off the rose" of embryonic stem cell research. The first is a January 17th editorial from Investor's Business Daily about the utter failure of California's $3 billion Proposition 71 ("When funding was needed, the phrase 'embryonic stem cells' was used. When actual progress was discussed, the word 'embryonic' was dropped because [the ESCR] never got out of the lab.") and the second is a January 19th Daily Mail story refering to even the International Society for Stem Cell Research admitting that "people’s expectations about stem cells are unrealistically high."